Nrf2-Mediated Metabolic Reprogramming in Cancer

Joint Authors

Liu, Xiaoming
Chen, Juan
Wang, Yan-Yang
Zhe, Hong
Zhao, Ren

Source

Oxidative Medicine and Cellular Longevity

Issue

Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2018-01-29

Country of Publication

Egypt

No. of Pages

7

Main Subjects

Biology

Abstract EN

Metabolic reprogramming is one of the hallmarks of cancer.

Nrf2 pathway is one of the critical signaling cascades involved in cell defense and survival against oxidative stress.

The significance of Nrf2 in cancer metabolism begins to be recognized.

In this minireview, we focus on the Nrf2-mediated cancer metabolic reprogramming and intend to highlight the role of Nrf2 in the regulation of malignant transformation, cancer proliferation, and the development of treatment resistance via metabolic adaptations.

We hope for the development of noninvasive biomarkers and novel therapeutic approaches for cancer based on Nrf2-directed cancer metabolic reprogramming in the near future.

American Psychological Association (APA)

Wang, Yan-Yang& Chen, Juan& Liu, Xiaoming& Zhao, Ren& Zhe, Hong. 2018. Nrf2-Mediated Metabolic Reprogramming in Cancer. Oxidative Medicine and Cellular Longevity،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1212371

Modern Language Association (MLA)

Wang, Yan-Yang…[et al.]. Nrf2-Mediated Metabolic Reprogramming in Cancer. Oxidative Medicine and Cellular Longevity No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1212371

American Medical Association (AMA)

Wang, Yan-Yang& Chen, Juan& Liu, Xiaoming& Zhao, Ren& Zhe, Hong. Nrf2-Mediated Metabolic Reprogramming in Cancer. Oxidative Medicine and Cellular Longevity. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1212371

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1212371